324 related articles for article (PubMed ID: 25288176)
1. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes.
Johnston CA; Moreno JP; Foreyt JP
Curr Atheroscler Rep; 2014 Dec; 16(12):457. PubMed ID: 25288176
[TBL] [Abstract][Full Text] [Related]
2. The Look AHEAD Trial: Implications for Lifestyle Intervention in Type 2 Diabetes Mellitus.
Dutton GR; Lewis CE
Prog Cardiovasc Dis; 2015; 58(1):69-75. PubMed ID: 25936906
[TBL] [Abstract][Full Text] [Related]
3. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial.
; Wing RR
Arch Intern Med; 2010 Sep; 170(17):1566-75. PubMed ID: 20876408
[TBL] [Abstract][Full Text] [Related]
4. Prospective association of a genetic risk score and lifestyle intervention with cardiovascular morbidity and mortality among individuals with type 2 diabetes: the Look AHEAD randomised controlled trial.
Look AHEAD Research Group
Diabetologia; 2015 Aug; 58(8):1803-13. PubMed ID: 25972230
[TBL] [Abstract][Full Text] [Related]
5. Long-term effect of weight loss on obstructive sleep apnea severity in obese patients with type 2 diabetes.
Kuna ST; Reboussin DM; Borradaile KE; Sanders MH; Millman RP; Zammit G; Newman AB; Wadden TA; Jakicic JM; Wing RR; Pi-Sunyer FX; Foster GD;
Sleep; 2013 May; 36(5):641-649A. PubMed ID: 23633746
[TBL] [Abstract][Full Text] [Related]
6. The results of Look AHEAD do not row against the implementation of lifestyle changes in patients with type 2 diabetes.
Annuzzi G; Rivellese AA; Bozzetto L; Riccardi G
Nutr Metab Cardiovasc Dis; 2014 Jan; 24(1):4-9. PubMed ID: 24388434
[TBL] [Abstract][Full Text] [Related]
7. The role of lifestyle change for prevention of cardiovascular disease in diabetes.
Staimez LR; Weber MB; Gregg EW
Curr Atheroscler Rep; 2014 Dec; 16(12):460. PubMed ID: 25363453
[TBL] [Abstract][Full Text] [Related]
8. [Lifestyle-recommendations on weight loss in type 2 diabetes--useful, or not?].
Admiraal WM; Holleman F; Hoekstra JB
Ned Tijdschr Geneeskd; 2013; 157(43):A6813. PubMed ID: 24152367
[TBL] [Abstract][Full Text] [Related]
9. Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes.
Ryan DH; Espeland MA; Foster GD; Haffner SM; Hubbard VS; Johnson KC; Kahn SE; Knowler WC; Yanovski SZ;
Control Clin Trials; 2003 Oct; 24(5):610-28. PubMed ID: 14500058
[TBL] [Abstract][Full Text] [Related]
10. Association of BMI with cardiovascular disease incidence and mortality in patients with type 2 diabetes mellitus: A systematic review and dose-response meta-analysis of cohort studies.
Zhao Y; Qie R; Han M; Huang S; Wu X; Zhang Y; Feng Y; Yang X; Li Y; Wu Y; Liu D; Hu F; Zhang M; Sun L; Hu D
Nutr Metab Cardiovasc Dis; 2021 Jun; 31(7):1976-1984. PubMed ID: 33965298
[TBL] [Abstract][Full Text] [Related]
11. Obesity and cardiovascular disease: pathogenic mechanisms and potential benefits of weight reduction.
Douketis JD; Sharma AM
Semin Vasc Med; 2005 Feb; 5(1):25-33. PubMed ID: 15968577
[TBL] [Abstract][Full Text] [Related]
12. Sleep architecture following a weight loss intervention in overweight and obese patients with obstructive sleep apnea and type 2 diabetes: relationship to apnea-hypopnea index.
Shechter A; St-Onge MP; Kuna ST; Zammit G; RoyChoudhury A; Newman AB; Millman RP; Reboussin DM; Wadden TA; Jakicic JM; Pi-Sunyer FX; Wing RR; Foster GD;
J Clin Sleep Med; 2014 Nov; 10(11):1205-11. PubMed ID: 25325608
[TBL] [Abstract][Full Text] [Related]
13. Targeting weight loss interventions to reduce cardiovascular complications of type 2 diabetes: a machine learning-based post-hoc analysis of heterogeneous treatment effects in the Look AHEAD trial.
Baum A; Scarpa J; Bruzelius E; Tamler R; Basu S; Faghmous J
Lancet Diabetes Endocrinol; 2017 Oct; 5(10):808-815. PubMed ID: 28711469
[TBL] [Abstract][Full Text] [Related]
14. Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial.
; Pi-Sunyer X; Blackburn G; Brancati FL; Bray GA; Bright R; Clark JM; Curtis JM; Espeland MA; Foreyt JP; Graves K; Haffner SM; Harrison B; Hill JO; Horton ES; Jakicic J; Jeffery RW; Johnson KC; Kahn S; Kelley DE; Kitabchi AE; Knowler WC; Lewis CE; Maschak-Carey BJ; Montgomery B; Nathan DM; Patricio J; Peters A; Redmon JB; Reeves RS; Ryan DH; Safford M; Van Dorsten B; Wadden TA; Wagenknecht L; Wesche-Thobaben J; Wing RR; Yanovski SZ
Diabetes Care; 2007 Jun; 30(6):1374-83. PubMed ID: 17363746
[TBL] [Abstract][Full Text] [Related]
15. Association of type 2 diabetes susceptibility loci with one-year weight loss in the look AHEAD clinical trial.
Peter I; McCaffery JM; Kelley-Hedgepeth A; Hakonarson H; Reis S; Wagenknecht LE; Kopin AS; Huggins GS;
Obesity (Silver Spring); 2012 Aug; 20(8):1675-82. PubMed ID: 22307069
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity of Treatment Effects From an Intensive Lifestyle Weight Loss Intervention on Cardiovascular Events in Patients With Type 2 Diabetes: Data From the Look AHEAD Trial.
de Vries TI; Dorresteijn JAN; van der Graaf Y; Visseren FLJ; Westerink J
Diabetes Care; 2019 Oct; 42(10):1988-1994. PubMed ID: 31416897
[TBL] [Abstract][Full Text] [Related]
17. The use of electronic medical records for recruitment in clinical trials: findings from the Lifestyle Intervention for Treatment of Diabetes trial.
Effoe VS; Katula JA; Kirk JK; Pedley CF; Bollhalter LY; Brown WM; Savoca MR; Jones ST; Baek J; Bertoni AG;
Trials; 2016 Oct; 17(1):496. PubMed ID: 27733193
[TBL] [Abstract][Full Text] [Related]
18. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study.
Li G; Zhang P; Wang J; Gregg EW; Yang W; Gong Q; Li H; Li H; Jiang Y; An Y; Shuai Y; Zhang B; Zhang J; Thompson TJ; Gerzoff RB; Roglic G; Hu Y; Bennett PH
Lancet; 2008 May; 371(9626):1783-9. PubMed ID: 18502303
[TBL] [Abstract][Full Text] [Related]
19. Effects of weight loss intervention on erectile function in older men with type 2 diabetes in the Look AHEAD trial.
Wing RR; Rosen RC; Fava JL; Bahnson J; Brancati F; Gendrano Iii IN; Kitabchi A; Schneider SH; Wadden TA
J Sex Med; 2010 Jan; 7(1 Pt 1):156-65. PubMed ID: 19694925
[TBL] [Abstract][Full Text] [Related]
20. Intensive lifestyle intervention combined with the choice of pharmacotherapy improves weight loss and cardiac risk factors in the obese.
Frost G; Lyons F; Bovill-Taylor C; Carter L; Stuttard J; Dornhorst A
J Hum Nutr Diet; 2002 Aug; 15(4):287-95; quiz 297-9. PubMed ID: 12153502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
